Clinical Trial

Radiolabeled TSPO Targeted Molecular Probe in AMI

Name: Radiolabeled TSPO Targeted Molecular Probe in AMI — clinical trial record (NCT07105982)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium \[68Ga\]-DOTA-HK-011 for inflammation imaging associated with acute myocardial infarction.

Trial Details

NCT Number	NCT07105982
Lead Sponsor	Nanjing First Hospital, Nanjing Medical University
Conditions	Acute Myocardial Infarction (AMI)
Enrollment	8 participants
Start Date	2025-09-01
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-06